Clinical Trials List
2024-01-01 - 2027-11-14
Phase III
Recruiting7
ICD-10C76.0
Malignant neoplasm of head, face and neck
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9195.0
Malignant neoplasm of other and ill-defined sites of head, face and neck
-
Trial Applicant
WORLDWIDE CLINICAL TRIALS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳珈妤 無
- Yu-Min Liao 無
- Ming-Yu Lien 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- RUEY-LONG HONG 無
- 楊明翰 無
- Hsiang-Fong Kao 無
- 廖斌志 無
- 王郁棻 無
- 黃彥霖 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 劉奕廷 無
- Shang-Yin Wu 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 廖俊達 無
- Li-Yu Lee 無
- Chi-Ting Liau 無
- 葉智華 無
- Cheng-Lung Hsu 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
24 participants
-
Global
410-500 participants
